Astria Therapeutics Inc (ATXS)
12.58
+0.00%
Astria Therapeutics Inc (ATXS) is currently trading at $12.58. This represents a gain of 0% from the previous session. With a market capitalization of $0.72B, ATXS is a key component of the Health Care sector. Investors looking to trade ATXS should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade ATXS commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Astria Therapeutics Inc (ATXS) shows a bullish trend. Analysts are watching the 0.00 level closely.
Fundamentals
Mkt Cap0.72B
P/E Ratio0.0000
Volume0
60-Day Technical Chart
Advanced Charting
Need more indicators for ATXS? Use the world's #1 platform.
Open ATXS on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $13
| Metric |
ATXS +0.00% |
SMR -1.27% |
AAL +0.53% |
EOSE -0.74% |
|---|---|---|---|---|
| Price | $12.58 | $13.28 | $13.20 | $11.39 |
| Mkt Cap | $0.72B | $4.02B | $8.67B | $3.65B |
| - | View → | View → | View → |
Latest Headlines
Astria Therapeutics Stock Rallies 37% on $700M Buyout Offer From BCRX
Yahoo Finance • Oct 15, 2025
Astria Therapeutics stock soars after BioCryst acquisition announcement, BioCryst falls
Investing.com • Oct 14, 2025
Astria Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
Business Wire • Nov 12, 2025
ATXS Stocks Flying High: Too Late to Buy?
StocksToTrade • Oct 14, 2025
Astria Therapeutics: Updating Target Price, BioCryst Deal Expected To Go Through, Hold
Seeking Alpha • Nov 30, 2025
● Gemini Agentic AI Analyst Insight for ATXS
Market Education
- From Small Players to Market Movers: How Former Small Caps Are Scaling Up Sep 27, 2025
- Making Sense of Money: How Interest Rates, Bonds, and Stocks Affect Your Wallet Feb 21, 2024
- Bridgewater Associate Top Stocks Nov 20, 2023
External Research